nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A myth of the well-stirred model: Is the well-stirred model good for high clearance drugs?
|
Dong, Jin |
|
|
172 |
C |
p. |
artikel |
2 |
Bio-physical and computational studies on serum albumin / target protein binding of a potential anti-cancer agent
|
SreedharanNair, Sreedhanya |
|
|
172 |
C |
p. |
artikel |
3 |
Corrigendum to ’Double-dose cefuroxime concentrations in bone, synovial fluid of the knee joint and subcutaneous adipose tissue-A randomised porcine microdialysis study’ [Eur J Pharm Sci. 160 (2021) 105754]
|
Jørgensen, Andrea René |
|
|
172 |
C |
p. |
artikel |
4 |
DL-3-n-butylphthalide prevents oxidative stress and atherosclerosis by targeting Keap-1 and inhibiting Keap-1/Nrf-2 interaction
|
Han, Jibo |
|
|
172 |
C |
p. |
artikel |
5 |
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue
|
Degerstedt, Oliver |
|
|
172 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
|
172 |
C |
p. |
artikel |
7 |
Effect of ingested fluid volume and solution osmolality on intestinal drug absorption: Impact on drug interaction with beverages
|
Funai, Yuta |
|
|
172 |
C |
p. |
artikel |
8 |
Evaluation of efficacy and safety after replacement of methyl hydrogen with deuterium at methyl formate of Clopidogrel
|
Xu, Zhiping |
|
|
172 |
C |
p. |
artikel |
9 |
Faster to First-time-in-Human: Prediction of the liquid solid ratio for continuous wet granulation
|
Junnila, Atte |
|
|
172 |
C |
p. |
artikel |
10 |
From pluripotent stem cells to bioengineered islets: A challenging journey to diabetes treatment
|
Carvalho, Ana Margarida |
|
|
172 |
C |
p. |
artikel |
11 |
Impact of four inorganic impurities – iron, copper, nickel and zinc - on the quality attributes of a Fc-fusion protein upon incubation at different temperatures
|
Pistacchio, Alessandra |
|
|
172 |
C |
p. |
artikel |
12 |
Infrared and Raman spectroscopy for purity assessment of extracellular vesicles
|
Zini, Jacopo |
|
|
172 |
C |
p. |
artikel |
13 |
Initiation of an Emulsion Microinfusion: Flow Direction Influences Delivery Onset Rate
|
Tsao, Amy C. |
|
|
172 |
C |
p. |
artikel |
14 |
Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective
|
Wilson, Clive G. |
|
|
172 |
C |
p. |
artikel |
15 |
In vitro investigation of the principle of action of ammonium bituminosulfonate ointments on a 3D skin model
|
Fink, Sarah |
|
|
172 |
C |
p. |
artikel |
16 |
Linear solvation energy relationships (LSERs) for robust prediction of partition coefficients between low density polyethylene and water. Part I: Experimental partition coefficients and model calibration
|
Egert, Thomas |
|
|
172 |
C |
p. |
artikel |
17 |
Linear solvation energy relationships (LSERs) for robust prediction of partition coefficients between low density polyethylene and water. Part II: Model evaluation and benchmarking
|
Egert, Thomas |
|
|
172 |
C |
p. |
artikel |
18 |
Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates
|
Cossette, Chantal |
|
|
172 |
C |
p. |
artikel |
19 |
Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions
|
Schiller, Hilmar |
|
|
172 |
C |
p. |
artikel |
20 |
Particle engineering in dry powders for inhalation
|
Scherließ, Regina |
|
|
172 |
C |
p. |
artikel |
21 |
Quercetin, Rutin And Quercetin-Rutin Incorporated Hydroxypropyl β-Cyclodextrin Inclusion Complexes
|
BAŞARAN, Ebru |
|
|
172 |
C |
p. |
artikel |
22 |
Significant growth inhibition by a bispecific affibody targeting oncoprotein E7 in both HPV16 and 18 positive cervical cancer in vitro and in vivo
|
Tan, Xiaochun |
|
|
172 |
C |
p. |
artikel |
23 |
System model driven selection of robust tablet manufacturing processes based on drug loading and formulation physical attributes
|
White, Leah R. |
|
|
172 |
C |
p. |
artikel |
24 |
Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activity
|
Anbar, Hanan S. |
|
|
172 |
C |
p. |
artikel |